Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health Care Spending Boosted By ACA Coverage, Hep-C Drugs

This article was originally published in The Gray Sheet

Executive Summary

The health care spending growth rate in the US leapt to 5.3% in 2014 – much higher than in the prior three years – led by coverage expansions under the Affordable Care Act and new drug treatments for hepatitis C, says an annual health expenditures report. Costs for durable medical equipment grew 3.2% in 2014 from prior-year levels.

You may also be interested in...



Health Spending Growth Sees 5.5 Percent Rise After Years Of Recession Lows

National health care spending grew 5.5 percent between 2013 and 2014 after years of more modest increases linked to the recession, CMS actuaries said. Also, DME growth dropped from 4.2 to 2.9 percent last year, but will rise by 5.1 percent by the end of 2015, according to the Medicare agency.

Health And Wellness Trademark Review 1 December, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Ipsen CEO Outlines Strategy For Long-Term Success

While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.

Topics

Related Companies

UsernamePublicRestriction

Register

OM013133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel